Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S. Gen Dent. 2010 Nov-Dec; 58(6):484-92; quiz 493-4.
View in:
PubMed
subject areas
Administration, Oral
Administration, Oral
Adrenal Cortex Hormones
Adrenal Cortex Hormones
Aged
Aged
Alendronate
Alendronate
Bone Density Conservation Agents
Bone Density Conservation Agents
Breast Neoplasms
Breast Neoplasms
Databases as Topic
Databases as Topic
Diphosphonates
Diphosphonates
Etidronic Acid
Etidronic Acid
Female
Female
Humans
Humans
Imidazoles
Imidazoles
Injections, Intravenous
Injections, Intravenous
Jaw Diseases
Jaw Diseases
Lung Neoplasms
Lung Neoplasms
Male
Male
Middle Aged
Middle Aged
Multiple Myeloma
Multiple Myeloma
Neoplasms
Neoplasms
Oral Surgical Procedures
Oral Surgical Procedures
Osteitis
Osteitis
Osteomyelitis
Osteomyelitis
Osteoporosis
Osteoporosis
Prevalence
Prevalence
Prostatic Neoplasms
Prostatic Neoplasms
Risk Factors
Risk Factors
United States
United States
authors with profiles
Grant H Skrepnek